Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia

Alfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, Guillermo Garcia-Manero, Mary B. Rios, Moshe Talpaz, Jorge Cortes

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences